J.P. Morgan’s head of life sciences for commercial banking shares biopharma industry insights for 2018 (Q&A)
Peter Meath, Managing Director and Head of Life Sciences for J.P. Morgan’s Commercial Banking business, shared his perspective on what will happen in the biopharma industry in 2018.